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Background: The lung clearance index (LCI) from the multiple-breath inert gas
washout (MBW) test is an index of ventilation distribution reﬂecting peripheral
airway function. It is more sensitive to lung involvement in CF than spirometry (ERJ
2003;22:972−9) and correlates more closely with HRCT structural lung damage
(Thorax e-pub Aug 3, 2007). It was hypothesized that LCI can stabilise or even
improve in a signiﬁcant proportion of the cohort over the course of several years
and that LCI may be higher and progress faster in patients with vs. without chronic
Ps aeruginosa colonisation (PA).
Methods and Subjects: CF subjects born in 1993 or later, who had performed at
least 3 MBW tests over a period of >12 month (N= 35) were included and separated
into 3 groups: chronic PA (CC, n = 5), intermittent PA (IC, n = 10) and never PA
(NC, n = 20). Age at ﬁrst LCI was 2.2 (0.2–7.5) yrs [median (range)] and follow-up
time was 4.6 (1.1–11.2) yrs.
Results: LCI did not correlate with age at ﬁrst or ﬁnal LCI, with age at diagnosis,
genotype or pancreatic status. Regression analysis showed a signiﬁcant improvement
in LCI in relation to the MBW test number (p = 0.005) with no signiﬁcant difference
between ﬁrst and last LCI in either group. CC had already at start a high LCI
compared to NC (p< 0.01). CC also deteriorated in LCI initially when becoming
chronically colonized, but 4/5 subjects improved in LCI with more intensive
treatment. NC remained stable all through follow-up.
Conclusion: The course of small airway function in CF as determined by LCI is
variable, but in general not progressive.
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Background: The lung clearance index (LCI) from multiple-breath washout
(MBW) is known to detect abnormal lung function more sensitive than spirometry
in children and teenagers with Cystic ﬁbrosis (CF). First data comparing LCI and
FEV1 in adults with CF had recently been published by A. Horsley et al.
The purpose of this study was to investigate LCI in adult, healthy subjects and
patients with CF by a different new device.
Methods: Lung function was measured in 34 healthy, non-smoking adults (18−42
years) and 13 patients with CF (19−47 years). LCI was calculated from multiple
breath inert gas dilution measurements with a modiﬁed ultrasonic ﬂow sensor (main-
stream and sidestream) using 25% helium as an inert tracer gas (Exhalyzer® D,
Ecomedics, Switzerland). Spirometry including FEV1 was performed and inter-
preted according to the ATS/ERS recommendations (MasterScreen PFT, Erich
Jaeger GmbH, Germany).
Results: LCI and FEV1% predicted in healthy adults was signiﬁcantly different
from that in CF patients (mean: FEV1%predicted: 108% vs. 60%; LCI: 6.3 vs.
10.4; p< 0.001). In a small subgroup of four patients with normal FEV1 (80%
predicted) LCI differed signiﬁcantly from the healthy controls (mean: 8.2 vs. 6.3;
p< 0.001). In CF patients LCI increased with reducing FEV1% predicted (r2 = 0.67,
p< 0.001).
Conclusion: Abnormal LCI was found in the majority of adults with cystic ﬁbrosis.
LCI is even increased in adults with normal FEV1 (80% predicted). The modiﬁed
Exhalyzer® D is a reliable device to ascertain reproducible data for calculating LCI.
Our results agree very well with those from a similar previous study (A. Horsley
et al., Thorax 2007) using a modiﬁed Innocor™ system.
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Background: The lung clearance index (LCI) from the multiple-breath inert gas
washout (MBW) test, an index of ventilation inhomogeneity, is more sensitive to
lung involvement in CF than spirometry (ERJ 2003;22:972−9) and more closely
related to HRCT structural lung damage (Thorax Aug 3, 2007, e-pub). It is unknown
to what extent the LCI reﬂects irreversible structural and potentially reversible
inﬂammatory processes. It was hypothesized that LCI may improve if it at least
partially measures reversible lung pathology.
Methods and Subjects: LCI was followed in 5 children with chronic Pseudomonas
aeruginosa colonisation (CC) and 10 with intermittent colonisation (IC) diagnosed
at their last MBW test. Median (range) follow-up time was 10.2 (6.7–11.2) and
6.5 (1.1–11.2) yrs, respectively, with 7 (3–10) follow-up visits in both groups. The
number of i.v antibiotic courses given per year was compared.
Results: LCI tended to be higher in children with CC vs IC group already at the
ﬁrst MBW (median 10.8 (7.8−13.6) vs 8.3 (6.0−13.0); p = 0.17). LCI improved in
4/5 with CC and 7/10 with IC during the study period, being 9.2 (7.4−10.0) and
7.4 (6.5−10.5), respectively at the last test (p = 0.07). The median (range) number
of i.v antibiotic courses per subject and year during follow up was 2.1 (1.3−2.9) in
CC and 1.3 (0.2−3.0) in IC (p = 0.21).
Conclusion: Small airway dysfunction in CF is not necessarily progressive even
in subjects with chronic or intermittent Pseudomonas aeruginosa colonisation,
supporting the view that aggressive early intervention is important.
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All pts with CF are at risk of developing liver disease. End-stage liver disease
is a signiﬁcant cause of morbidity and mortality with liver transplantation (LTx)
being the only effective therapy. Isolated LTx may produce considerable extrahepatic
beneﬁts for the patient.
The aim of this study is to describe retrospectively the long term effect of LTx on
pulmonary function, nutritional status and sputum microbiology in CF pts.
Material and Methods: 5 CF pts were the recipients of 5 liver allografts (4 from
cadaveric and 1 from related donor). There were 3 boys and 2 girls with a mean
age at LTx of 11.4 years (range 7.5−18).
Results: The mean follow-up was 4.8 years (range 1.7−6.9). Sputum cultures
pre- and postLTx were analyzed. All the pts had documented positive sputum
cultures before LTx (2 with S. aureus and P. aeruginosa, 1 with S. aureus and
H. inﬂuenzae, 1 with H.inﬂuenzae, 1 with S.pneumoniae) and only 4 after LTx
(2 with P. aeruginosa, 2 with S. aureus). All the pts were malnourished with BMI 16
before LTx which increased to 18 after LTx. Pre- and postLTx pulmonary function
tests were assessed. VC and FEV1 changed from a mean of 85% and 91% of
predicted preLTX to 86% and 82% of predicted postLTx respectively.
Conclusions: Although complications of CF liver disease can be managed without
transplantation, LTx remains the only curative treatment for liver failure. In our
studies we observed improvement in nutritional status, no considerable changes
in the bacterial colonization and no signiﬁcant deterioration in PFTs. Therefore,
liver transplantation should be considered early in the course of liver failure in pts
with CF.
